← Open Payments lookup

CONSTANCE GAWUM: Open Payments

NPI 1356609754 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,480 in 72 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $156 · 2025 $1,480

Food & beverage: $1,480
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$404
Alkermes, Inc.15$283
Otsuka America Pharmaceutical, Inc.11$216
ABBVIE INC.9$163
Teva Pharmaceuticals USA, Inc.6$141
E.R. Squibb & Sons, L.L.C.5$111
Janssen Pharmaceuticals, Inc3$102
Vanda Pharmaceuticals Inc.1$40
Neurocrine BioSciences, Inc.1$23

Products named: CAPLYTA, ARISTADA, VRAYLAR, LYBALVI, COBENFY, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.